UNIVERSITY OF CINCINNATI
Targeting fibrosis to change cancer outcomes
Targeting fibrosis to change cancer outcomes is a funding opportunity from UNIVERSITY OF CINCINNATI, up to 49524, closing August 16, 2028.
Aug 16, 2028
(747d left)Overview
PROJECT SUMMARY Scleroderma (SSc) patients have more than a 300% increased risk of lung cancer, or Cancerous Scleroderma (CSc). SSc is a chronic autoimmune connective tissue disease of unknown etiology, and has the highest morbidity of all rheumatologic diseases. Moreover, aging is a key risk factor in SSc patients…